We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Ask ADVFN Intelligence (AI)
GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of MedImmune by AstraZeneca PLC pursuant to a...
Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that the company was...
- 10th Consecutive Year for MedImmune on the Fast 50 List - GAITHERSBURG, Md., Sept. 29 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named to Deloitte's Maryland Technology Fast 50 program...
GAITHERSBURG, Md., Oct. 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named to Deloitte's Maryland Technology Fast 50 program for the ninth consecutive year. The Technology Fast 50 is a...
Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/ -- Standard & Poor's will make its semi-annual changes...
Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Data presented today from a Phase 3...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 4 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 26 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 52 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 156 | 0 | 0 | 1.85 | 1.85 | 1.85 | 0 | 0 | CS |
| 260 | -4.65 | -71.5384615385 | 6.5 | 6.5 | 0.26 | 2450 | 1.14491134 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
